|
[1]LEE YA,WALLACE MC,FRIEDMAN SL.Pathobiology of liver fibrosis:a translational success story[J].Gut,2015,64(5):830-841.
|
|
[2]PUCHE JE,SAIMAN Y,FRIEDMAN SL.Hepatic stellate cells and liver fibrosis[J].Compr Physiol,2013,3(4):1473-1492.
|
|
[3]GOTO K,LIN W,ZHANG L,et al.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-βsignaling[J].J Hepatol,2013,59(5):942-948.
|
|
[4]LI T,YAN Y,WANG B,et al.Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis[J].Stem Cells Dev,2013,22(6):845-854.
|
|
[5]WANG SY,YUAN MZ,LIU XD,et al.Advance research on relationship between cytokines and pulmonary fibrosis[J].J Jilin Univ:Med Edit,2014,40(6):1325-1329.(in Chinese)王司仪,原铭贞,刘笑玎,等.细胞因子与肺纤维化相关性的研究进展[J].吉林大学学报:医学版,2014,40(6):1325-1329.
|
|
[6]YANG L,PANG Y,MOSES HL.TGF-beta and immune cells:an important regulatory axis in the tumor microenvironment and progression[J].Trends Immunol,2010,31(6):220-227.
|
|
[7]WU FR,PAN CX,RONG C,et al.Inhibition of acid-sensing ion channel 1a in hepatic stellate cells attenuates PDGF-induced activation of HSCs through MAPK pathway[J].Mol Cell Biochem,2014,395(1):199-209.
|
|
[8]OGAWA S,OCHI T,SHIMADA H,et al.Anti-PDGF-B monoclonal antibody reduces liver fibrosis development[J].Hepatol Res,2010,40(11):1128-1141.
|
|
[9]HONG F,CHOU H,FIEL MI,et al.Antifibrotic activity of sorafenib in experimental hepatic fibrosis:refinement of inhibitory targets,dosing,and window of efficacy in vivo[J].Dig Dis Sci,2013,58(1):257-264.
|
|
[10]ABDEL-MONEIM AM,AL-KAHTANI MA,EL-KERSH MA,et al.Free radical-scavenging,anti-inflammatory/anti-fibrotic and hepatoprotective actions of taurine and silymarin against CCl4induced rat liver damage[J].PLo S One,2015,10(12):e0144509.
|
|
[11]HANDY JA,FU PP,KUMAR P,et al.Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis[J].Biochem J,2011,440(3):385-395.
|
|
[12]ZHOU Q,GUAN W,QIAO H,et al.GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation[J].Biochim Biophys Acta,2014,1842(12):2367-2377.
|
|
[13]WANG MJ,MA H.Role of adiponectin in liver fibrogenesis:progress in basic and clinical research[J].J Clin Hepatol,2011,27(3):321-324.(in Chinese)王美娟,马红.脂联素在肝纤维化发生中的作用[J].临床肝胆病杂志,2011,27(3):321-324.
|
|
[14]DONG Z,SU L,ESMAILI S,et al.Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells[J].J Mol Med(Berl),2015,93(12):1327-1339.
|
|
[15]CHEN L,CHARRIER AL,LEASK A,et al.Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor[J].J Hepatol,2011,55(2):399-406.
|
|
[16]GRESSNER OA,LAHME B,DEMIRCI I,et al.Differential effects of TGF-βon connective tissue growth factor(CTGF/CCN2)expression in hepatic stellate cells and hepatocytes[J].J Hepatol,2007,47(5):699-710.
|
|
[17]FERDOUSHI S,PAUL D,GHOSH CK.Correlation of connective tissue growth factor(CTGF/CCN2)with hepatic fibrosis in chronic hepatitis B[J].Mymensingh Med J,2015,24(3):558-563.
|
|
[18]WANG Q,USINGER W,NICHOLS B,et al.Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease[J].Fibrogenesis Tissue Repair,2011,4(1):1-11.
|
|
[19]MARRA F,TACKE F.Roles for chemokines in liver disease[J].Gastroenterology,2014,147(3):577-594.
|
|
[20]LIANG YJ,LUO J,LU Q,et al.Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells[J].PLo S One,2012,7(8):e42490.
|
|
[21]BARASHI N,WEISS ID,WALD O,et al.Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice[J].Hepatology,2013,58(3):1021-1030.
|
|
[22]SAHIN H,BORKHAM-KAMPHORST E,KUPPE C,et al.Chemokine CXCL9 attenuates liver fibrosis-associated angiogenesis in mice[J].Hepatology,2012,55(5):1610-1619.
|
|
[23]LIU LY,ALEXA K,CORTES M,et al.Cannabinoid receptor signaling regulates liver development and metabolism[J].Development,2016,143(4):609-622.
|
|
[24]GUILLOT A,HAMDAOUI N,BIZY A,et al.Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver[J].Hepatology,2014,59(1):296-306.
|
|
[25]YANG YY,TSAI TH,HUANG YT,et al.Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats[J].Hepatology,2012,55(5):1540-1550.
|
|
[26]HUANG HC,WANG SS,HSIN IF,et al.Cannabinoid receptor 2agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats[J].Hepatology,2012,56(1):248-258.
|
|
[27]de MINICIS S,CANDELARESI C,MARZIONI M,et al.Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo[J].Gut,2008,57(3):352-364.
|
|
[28]KIM DC,JUN DW,KWON YI,et al.5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis[J].Liver Int,2013,33(4):535-543.
|
|
[29]ZVIBEL I,ATIAS D,PHILLIPS A,et al.Thyroid hormones induce activation of rat hepatic stellate cells through increased expression of p75 neurotrophin receptor and direct activation of Rho[J].Lab Invest,2010,90(5):674-684.
|
|
[30]FERNANDEZ M.Molecular pathophysiology of portal hypertension[J].Hepatology,2015,61(4):1406-1415.
|
|
[31]FALLOWFIELD JA,HAYDEN AL,SNOWDON VK,et al.Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo[J].Hepatology,2014,59(4):1492-1504.
|
|
[32]DUONG HT,DONG Z,SU L,et al.The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension[J].Small,2015,11(19):2291-2304.
|
|
[33]ZHAN L,HUANG C,MENG XM,et al.Hypoxia-inducible factor-1alpha in hepatic fibrosis:a promising therapeutic target[J].Biochimie,2015,108(1):1-7.
|
|
[34]SCHNABL B,BRENNER DA.Interactions between the intestinal microbiome and liver disease[J].Gastroenterology,2014,146(6):1513-1524.
|
|
[35]CHEN Y,CHOI SS,MICHELOTTI GA,et al.Hedgehog controls hepatic stellate cell fate by regulating metabolism[J].Gastroenterology,2012,143(5):1319-1329.
|
|
[36]MANN DA.Epigenetics in liver disease[J].Hepatology,2014,60(4):1418-1425.
|
|
[37]OLSEN AL,BLOOMER SA,CHAN EP,et al.Hepatic stellate cells require a stiff environment for myofibroblastic differentiation[J].Am J Physiol Gastrointest Liver Physiol,2011,301(1):g110-g118.
|
|
[38]MUNOZ-ESPIN D,SERRANO M.Cellular senescence:from physiology to pathology[J].Nat Rev Mol Cell Biol,2014,15(7):482-496.
|
|
[39]ZENG YL,ZHANG XJ,SHANG J,et al.Single-chain human anti-EGFR antibody/truncated protamine fusion protein carrying Hsp47 siRNA can induce apoptosis of human hepatic stellate cells[J].Chin J Hepatol,2014,22(11):843-848.(in Chinese)曾艳丽,张晓菊,尚佳,等.携带Hsp47特异性siRNA的人源单链抗体融合蛋白诱导人原代肝星状细胞凋亡研究[J].中华肝脏病杂志,2014,22(11):843-848.
|
DownLoad: